Surgery Partners, Inc. (SGRY)
| Market Cap | 1.84B |
| Revenue (ttm) | 3.31B |
| Net Income (ttm) | -77.90M |
| Shares Out | 128.21M |
| EPS (ttm) | -0.61 |
| PE Ratio | n/a |
| Forward PE | 77.63 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 934,546 |
| Open | 14.47 |
| Previous Close | 14.54 |
| Day's Range | 14.34 - 14.70 |
| 52-Week Range | 11.41 - 24.18 |
| Beta | 1.99 |
| Analysts | Buy |
| Price Target | 22.25 (+55.05%) |
| Earnings Date | May 5, 2026 |
About SGRY
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care faciliti... [Read more]
Financial Performance
In 2025, Surgery Partners's revenue was $3.31 billion, an increase of 6.24% compared to the previous year's $3.11 billion. Losses were -$77.90 million, -53.66% less than in 2024.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for SGRY stock is "Buy." The 12-month stock price target is $22.25, which is an increase of 55.05% from the latest price.
News
Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., April 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced th...
Surgery Partners, Inc. Names Lloyd Dean to Board of Directors
BRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) recently announced that Lloyd Dean has been appointed to serve as an ind...
Surgery Partners Transcript: Barclays 28th Annual Global Healthcare Conference
Shifts in payer mix, particularly increased Medicare cases, compressed margins despite higher procedure volumes. Cost reduction, portfolio optimization, and a conservative approach to guidance are underway, with a focus on deleveraging and maintaining high patient experience.
Ortelius Delivers Open Letter to Surgery Partners Stockholders
NEW YORK--(BUSINESS WIRE)--Ortelius Advisors, L.P. today issued the following open letter to stockholders of Surgery Partners, Inc. (NASDAQ: SGRY). March 10, 2026 Fellow Stockholders, Ortelius Advisor...
Surgery Partners, Inc. to Present at Upcoming Investor Conference
BRENTWOOD, Tenn., March 09, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), is scheduled to meet with investors at the Barclays 28th Annual Global ...
ZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERS
CHICAGO, March 4, 2026 /PRNewswire/ -- Ziegler, a specialty investment bank, is pleased to announce that it served as the exclusive financial advisor to Preferred Vascular Group (PVG) in connection wi...
Surgery Partners, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Surgery Partners, Inc. (NASDAQ: SGRY). The investigation focuses on Surge...
Surgery Partners Earnings Call Transcript: Q4 2025
2025 revenue and EBITDA grew but missed expectations due to margin pressure in three surgical hospital markets from payer mix shifts and cost increases. 2026 guidance reflects continued headwinds, with a focus on portfolio optimization, disciplined capital allocation, and organic growth in higher acuity procedures.
Surgery Partners, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the...
Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering
BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that its wholly-owned subsidiary, Surgery Center Holdings...
Surgery Partners, Inc. Announces Add-On Senior Notes Offering
BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced tod...
Surgery Partners Earnings Call Transcript: Q3 2025
Q3 2025 saw 6.6% revenue growth and stable margins, but guidance was revised downward due to softer commercial volumes, delayed M&A, and divestitures. The M&A pipeline remains strong, and de novo facility expansion continues, with a focus on long-term growth and portfolio optimization.
Duly Health and Care Expands Outpatient Surgery Access Through Minority Share Acquisition of Valley ASC in Partnership with Surgery Partners
DOWNERS GROVE, Ill.--(BUSINESS WIRE)--Duly Health and Care, through its Chicagoland medical group, DuPage Medical Group, Ltd., has announced the acquisition of a minority ownership interest in Valley ...
Surgery Partners Earnings Call Transcript: Q2 2025
Q2 2025 saw 8.5% revenue and 9% adjusted EBITDA growth, driven by strong organic and M&A performance. Guidance for 2025 is reaffirmed, with growth expected at the high end of targets and margin expansion continuing. Strategic review concluded with a focus on portfolio optimization and self-funded growth.
Surgery Partners, Inc. Announces Second Quarter 2025 Results
BRENTWOOD, Tenn., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announc...
Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., July 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the...
Surgery Partners Rejects Bain Capital's Private Buyout Offer, Will Remain Independent
Surgery Partners, Inc. SGRY received a non-binding proposal from Bain Capital Private Equity in January for a cash consideration of $25.75 per share.
Surgery Partners rejects Bain Capital's take-private offer
Surgery Partners said on Tuesday it was unable to agree to the terms set by Bain Capital, its largest shareholder, to take the surgical facility operator private.
Surgery Partners Earnings Call Transcript: Q1 2025
First quarter revenue and adjusted EBITDA grew 8% and 7% year-over-year, respectively, driven by strong case growth in GI and orthopedics, robust de novo and M&A activity, and improved operating efficiencies. Full-year guidance is reaffirmed, with margin expansion and liquidity supporting ongoing growth.
Surgery Partners, Inc. Announces First Quarter 2025 Results; Reaffirms Full Year 2025 Guidance
BRENTWOOD, Tenn., May 12, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announce...
Advanced Aesthetics Plastic Surgery Partners with Ascend Aesthetic Partners to Strengthen a Collaborative Community Focused on Growth, Learning, and Patient Care
ATLANTA, May 06, 2025 (GLOBE NEWSWIRE) -- Advanced Aesthetics Plastic Surgery has joined Ascend Aesthetic Partners, forming a partnership rooted in shared values of collaboration, clinical excellence,...
Surgery Partners, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., April 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced th...
Surgery Partners Earnings Call Transcript: Q4 2024
Record 2024 results with revenue over $3B and Adjusted EBITDA above $500M, driven by strong organic growth, M&A, and margin expansion. 2025 guidance projects continued double-digit growth, with minimal exposure to policy risks and robust liquidity to support ongoing investments.
Surgery Partners, Inc. Announces Fourth Quarter 2024 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the...
Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital
BRENTWOOD, Tenn., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announ...